Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Hepatitis B Virus Testing Market: By Test Type, Anti-hepatitis B Surface Antibody Test, Hepatitis B Core Antigen Test, Anti-hepatitis B Core Antibody Test, HBV DNA Test, and Others), By Techniques, Enzyme-linked immunosorbent assay and Others), By End User and Region Forecast 2019-2030
Hepatitis B virus testing market size was valued at US$ 949.07 million in 2023 and is expected to reach US$ 1319.44 million by 2030, at a CAGR of 6.5% from the period 2024-2030. Increase in liver cancer cases, growing aging population, healthcare spending, and urbanization. leading to better monitoring and screening procedures. In addition, government initiatives to grow awareness in public, increase in R&D spending by companies, and growing demand for biomarker tests due to their accuracy are expected to boost the market during the forecast period.
However, factors such as lack of awareness in developing countries, stringent regulatory rules, rigid competition, and high cost of testing are expected to hamper the market over the forecast period. Hepatitis B is a liver disease caused by the Hepatitis B virus (HBV). Hepatitis B viral infection control ranges can form mild infection which lasts a few weeks and a chronic infection that may lead to liver disorders and even death. Hepatitis B is one of the global health problems. Hepatitis B can cause chronic infection and puts people at high risk of death from cirrhosis and liver cancer. The virus is transmitted through contact with the blood or other body fluids of an infected person.
According to the World Health Organization, 257 million people are living with hepatitis B virus infection worldwide, and in 2015, 887,000 hepatitis B resulted in deaths. this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, The global market report includes human demographics; regulatory scenario, and competition analysis with a vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analyzed the global market to better equip clients with possible investment opportunities across the regions (regional Investment hot spots) and market unmet needs (Product opportunities).
Study Period
2024-2030Base Year
2023CAGR
6.5%Largest Market
North-AmericaFastest Growing Market
Asia Pacific
The rise in global hepatitis B prevalence might be attributed to the growth of the hepatitis B diagnostic testing market. According to the World Health Organization, it affects more than 300 million people worldwide. Furthermore, it is well-known that its frequency is particularly high in the Western Pacific and African regions. Perinatal transmission and horizontal transfer by infected blood are both prominent causes of infection in endemic areas. Increased public awareness, as well as increased government and non-profit initiatives, all contribute to the market's growth. As people become more aware of the disease, it gets diagnosed earlier. Hepatitis B diagnostic tests are in high demand as a result of this. The global hepatitis B diagnostic testing market is expected to be hampered by a lack of common recommendations for hepatitis B diagnosis.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 949.07 million |
Market Size in 2030 |
US$ 1319.44 million |
Market CAGR |
6.5% |
By Test Type |
|
By Techniques |
|
By End User |
|
By Region |
|
Download Free Sample Report
The hepatitis b virus testing market size was valued at US$ 949.07 million in 2023 and is set to reach US$ 1319.44 million by 2030 at a CAGR of 6.5% from 2024-2030
The market key players are: Onsite Lab Holding AG (MedMira Inc.) (Switzerland) F. Hoffmann-La Roche (Switzerland) Abbott Laboratories (U.S.) Siemens AG (Siemens Healthcare GmbH) (Germany) Fisher Bioblock Bolding (Thermo Fisher Scientific) (France) Innovita biological technology Co. Ltd. (China) General Biologicals Corporation (Taiwan) Nantong Diagnos Biotechnology Co. Ltd. (China) Blue Cross Bio-Medical Co. Ltd. (China) BioGenex (U.S.) Abnova Corporation (U.S.)
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
1. Executive Summary |
2. Global Hepatitis B Virus Testing Market Introduction |
2.1.Global Hepatitis B Virus Testing Market - Taxonomy |
2.2.Global Hepatitis B Virus Testing Market - Definitions |
2.2.1.Test Type |
2.2.2.Techniques |
2.2.3.End Users |
2.2.4.Region |
3. Global Hepatitis B Virus Testing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Hepatitis B Virus Testing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Hepatitis B Virus Testing Market By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Hepatitis B Surface Antigen Test (HBsAg) |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Anti-hepatitis B Surface Antibody Test |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Hepatitis B Core Antigen Test (HBcAb) |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Anti-hepatitis B Core Antibody Test |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. HBV DNA Test |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Others |
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
6. Global Hepatitis B Virus Testing Market By Techniques, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. PCR |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Radioimmunoassay (RIA) |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Enzyme-linked immunosorbent assay (ELISA) |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Others |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Global Hepatitis B Virus Testing Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Diagnostic Centers |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Clinics |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. Global Hepatitis B Virus Testing Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. North America Hepatitis B Virus Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Hepatitis B Surface Antigen Test (HBsAg) |
9.1.2.Anti-hepatitis B Surface Antibody Test |
9.1.3.Hepatitis B Core Antigen Test (HBcAb) |
9.1.4.Anti-hepatitis B Core Antibody Test |
9.1.5.HBV DNA Test |
9.1.6.Others |
9.2. Techniques Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.PCR |
9.2.2.Radioimmunoassay (RIA) |
9.2.3.Enzyme-linked immunosorbent assay (ELISA) |
9.2.4.Others |
9.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Diagnostic Centers |
9.3.3.Clinics |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10. Europe Hepatitis B Virus Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Hepatitis B Surface Antigen Test (HBsAg) |
10.1.2.Anti-hepatitis B Surface Antibody Test |
10.1.3.Hepatitis B Core Antigen Test (HBcAb) |
10.1.4.Anti-hepatitis B Core Antibody Test |
10.1.5.HBV DNA Test |
10.1.6.Others |
10.2. Techniques Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.PCR |
10.2.2.Radioimmunoassay (RIA) |
10.2.3.Enzyme-linked immunosorbent assay (ELISA) |
10.2.4.Others |
10.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Diagnostic Centers |
10.3.3.Clinics |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11. Asia Pacific (APAC) Hepatitis B Virus Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Hepatitis B Surface Antigen Test (HBsAg) |
11.1.2.Anti-hepatitis B Surface Antibody Test |
11.1.3.Hepatitis B Core Antigen Test (HBcAb) |
11.1.4.Anti-hepatitis B Core Antibody Test |
11.1.5.HBV DNA Test |
11.1.6.Others |
11.2. Techniques Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.PCR |
11.2.2.Radioimmunoassay (RIA) |
11.2.3.Enzyme-linked immunosorbent assay (ELISA) |
11.2.4.Others |
11.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Diagnostic Centers |
11.3.3.Clinics |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12. Middle East and Africa (MEA) Hepatitis B Virus Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Hepatitis B Surface Antigen Test (HBsAg) |
12.1.2.Anti-hepatitis B Surface Antibody Test |
12.1.3.Hepatitis B Core Antigen Test (HBcAb) |
12.1.4.Anti-hepatitis B Core Antibody Test |
12.1.5.HBV DNA Test |
12.1.6.Others |
12.2. Techniques Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.PCR |
12.2.2.Radioimmunoassay (RIA) |
12.2.3.Enzyme-linked immunosorbent assay (ELISA) |
12.2.4.Others |
12.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Diagnostic Centers |
12.3.3.Clinics |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13. Latin America Hepatitis B Virus Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Hepatitis B Surface Antigen Test (HBsAg) |
13.1.2.Anti-hepatitis B Surface Antibody Test |
13.1.3.Hepatitis B Core Antigen Test (HBcAb) |
13.1.4.Anti-hepatitis B Core Antibody Test |
13.1.5.HBV DNA Test |
13.1.6.Others |
13.2. Techniques Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.PCR |
13.2.2.Radioimmunoassay (RIA) |
13.2.3.Enzyme-linked immunosorbent assay (ELISA) |
13.2.4.Others |
13.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Diagnostic Centers |
13.3.3.Clinics |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Onsite Lab Holding AG (MedMira Inc.) (Switzerland) |
14.2.2.F. Hoffmann-La Roche (Switzerland) |
14.2.3.Abbott Laboratories (U.S.) |
14.2.4.Siemens AG (Siemens Healthcare GmbH) (Germany) |
14.2.5.Fisher Bioblock Bolding (Thermo Fisher Scientific) (France) |
14.2.6.Innovita biological technology Co. Ltd. (China) |
14.2.7.General Biologicals Corporation (Taiwan) |
14.2.8.Nantong Diagnos Biotechnology Co. Ltd. (China) |
14.2.9.Blue Cross Bio-Medical Co. Ltd. (China) |
14.2.10.BioGenex (U.S.) |
14.2.11.Abnova Corporation (U.S.) |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players